Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript
Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.
Accelerate Diagnostics Inc (AXDX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 23,296,489 | $14,998,280 | 8.61% | ||
| 2. | Birchview Capital Matthew Strobeck | 225,239 | $882,936 | 0.69% | |
| 3. | Citadel Investment Group Ken Griffin | 15,446 | $60,548 | 0% | |
| 4. | Tudor Investment Corp Paul Tudor Jones | 14,114 | $55,327 | 0% | |
| 5. | Millennium Management Israel Englander | 13,947 | $54,672 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 100,000 | Director | 120,682 | 2024-01-23 | Filing | |
| $0.00 | 13,333 | Director | 20,927 | 2024-01-23 | Filing | |
| $0.00 | 16,666 | Director | 24,260 | 2024-01-23 | Filing | |
| $0.00 | 16,666 | Director | 453,224 | 2024-01-23 | Filing | |
| $1.60 | 50,000 | Officer | 433,411 | 2022-08-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.78 | 26,735 | Officer, Director | 162,919 | 2024-04-17 | Filing | |
| $0.86 | 26,545 | Officer, Director | 129,726 | 2024-04-12 | Filing | |
| $0.87 | 13,296 | Officer | 50,419 | 2024-04-09 | Filing | |
| $0.87 | 13,984 | Officer | 81,106 | 2024-04-09 | Filing | |
| $0.88 | 978 | Officer | 54,457 | 2024-04-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,219,724 | $4,781,318 | 0.6% | |
| 2. | 4,178,560 | $2,733,937 | 0.02% | |
| 3. | 3,133,920 | $1,910,792 | 0.66% | |
| 4. | 1,995,263 | $1,758,142 | 0.57% | |
| 5. | 306,637 | $1,202,017 | 0% |
News See All
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Accelerate Diagnostics, Inc. 2023 Third Quarter Results Conference Call. All participant’s will be in listen-only mode.
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Accelerate Diagnostics, Inc. 2023 Q2 Results Conference Call. [Operator Instructions].
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Accelerate Diagnostics Incorporated 2023 Q1 Results Conference Call. All participants will be in listen-only mode.
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Accelerate Diagnostics Fourth Quarter 2022 Earnings Conference Call. Please note, this event is being recorded.
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Accelerate Diagnostics Inc. Third Quarter 2022 Earnings Call. . I would now like to turn the conference over to Mr.
5 Biotech Stocks to Buy According to Matthew Strobeck's Birchview Capital
In this article, we discuss 5 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Hedge Fund and Insider Trading News: Marc Lasry, Archegos Capital Management, ExodusPoint Capital Management, Tucows Inc. (TCX), Savara Inc (SVRA), and More
Why David Einhorn’s value fund posted a large loss in September.
Is AXDX A Good Stock To Buy Now?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.
Accelerate Diagnostics Inc (AXDX): Hedge Funds Are Snapping Up
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Billionaire Hedge Funds
